Other
Premature Infants
0
Pipeline Programs↗
5
Active Trials↗
1
Companies Involved↗
Premature Infants is an early-stage landscape with 0 programs across 1 company. The most active players are Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
35
clinical trials
Completed21 · 60%
Terminated5 · 14%
Unknown status4 · 11%
Not yet recruiting2 · 6%
Enrolling by invitation2 · 6%
Recruiting1 · 3%
Clinical Trials
Trial Activity
35 trials
Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination.
Not yet recruiting·PPolish Mother Memorial Hospital Research Institute·Phase 1·NCT06889376·40 enrolled
Prophylactic IV Paracetamol in Extremely Premature Infants
Enrolling by invitation·—·Phase 2/3·NCT07067177·28 enrolled
The Impact of Masseter Muscle Thickness on the Feeding Process in Preterm Infants in Ultrasound Assessment - an Observational Study
Enrolling by invitation·PPolish Mother Memorial Hospital Research Institute·N/A·NCT07656467·30 enrolled
Metronidazole Pharmacokinetics (PK) in Premature Infants
Completed·—·Phase 1·NCT01222585·24 enrolled
Ibuprofen and Renal Function in Premature Infants
Completed·—·Phase 4·NCT00217191·120 enrolled
Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants
Completed·—·Phase 4·NCT00389909·85 enrolled
Lactulose Supplementation in Premature Infants
Completed·—·Phase 2·NCT00616876·28 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)